wang-lvy-24515-web

经验

Angitia Biopharmaceuticals Announces $120 Million Series C

December 17, 2024

Cooley advised Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases, on its $120 million Series C.

Read more

Related contacts

陆培祥
合伙人, 新加坡
徐璨
顾问律师, 上海
刘毅铭
上海办事处主管合伙人, 上海
Chadwick Mills
Partner, 旧金山
Charlie Kim
Partner, 圣地亚哥
汪晨
律师, 上海
魏 乐天
法律顾问, 上海
Brandon Lefebvre
Quantitative Analyst, 波士顿

Related Practices & Industries

Chimagen Biosciences Announces Sale of CMG1A46 to GSK

October 29, 2024

Cooley advised Chimagen Biosciences, a privately held biotechnology company, on its agreement to sell CMG1A46, a clinical-stage dual CD19 and CD20-targeted T-cell engager (TCE), to GSK, a global biopharma company, for an upfront payment of $300 million, plus success-based development and commercial milestone payments totaling up to $550 million.

Read more

Related contacts

Marya Postner
Partner, 帕罗奥图
刘毅铭
上海办事处主管合伙人, 上海
Zack Gong
Associate, 上海
Jenny Ge
Associate, 洛杉矶
徐璨
顾问律师, 上海
Natasha Kaye
Partner, 伦敦
Christopher Kimball
Partner, 华盛顿特区
Rama Padmanabhan
Partner, 圣地亚哥
Aaron Pomeroy
Partner, 科罗拉多
Jonathan Rivinus
Partner, 科罗拉多
Rachel Thorn
Partner, 纽约
David Wilson
Partner, 伦敦
David Burns
Special Counsel, 华盛顿特区
Sharon Connaughton
Special Counsel, 华盛顿特区
Andrew Epstein
Special Counsel, Seattle
王滨
资深顾问, 帕罗奥图
Robert Eisenbach
Of Counsel, 旧金山
Robert Eisenbach
Of Counsel, 旧金山
Natasha Leskovsek
Of Counsel, 华盛顿特区
Elizabeth Caruso
Associate, 纽约
Eerik Kukebal
Associate, 伦敦
Amanda Pacheco
Associate, 帕罗奥图
Leo Spicer-Phelps
Partner, 伦敦
苏伦嘎
律师, 上海
汪晨
律师, 上海
Zhijing Yu
Associate, 新加坡
魏 乐天
法律顾问, 上海

Related Practices & Industries

Jiangsu Hengrui Pharmaceuticals Out-Licenses GLP-1 Portfolio

May 17, 2024

Cooley advised Jiangsu Hengrui Pharmaceuticals, one of the largest pharmaceutical companies in China, on its licensing of global rights (excluding Greater China) for the development, production and commercialization of three of its proprietary glucagon-like peptide-1 (GLP-1) drugs to Hercules CM Newco, a newly established Delaware company.

Read more

Related contacts

张扬
合伙人, 上海
Dr. Bill Christiansen
Partner, Seattle
Sharon Connaughton
Special Counsel, 华盛顿特区
Annie Froehlich
Partner, 华盛顿特区
Zack Gong
Associate, 上海
Kevin King
Partner, 华盛顿特区
Edmond Lay
Partner, 圣地亚哥
Howard Morse
Partner, 华盛顿特区
Sarah Oliai
Associate, 华盛顿特区
W. Chad Shear
Partner, 圣地亚哥
沈亨达
顾问律师, 上海
Dr. Xixi Sun
Associate, 波士顿
Alan W. Tamarelli
Partner, 纽约
Karen Tsai
Special Counsel, 华盛顿特区
汪晨
律师, 上海
王滨
资深顾问, 帕罗奥图
魏 乐天
法律顾问, 上海
Dr. Heng Zhang
Patent Agent , 波士顿
Dr. Tian Yong Zheng
Patent Agent, Seattle
Joanna Zhang
Associate, 圣地亚哥

Related Practices & Industries

ProfoundBio Announces $1.8 Billion Acquisition by Genmab

April 3, 2024

Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its definitive agreement to be acquired for $1.8 billion in an all-cash transaction by Genmab (NASDAQ: GMAB), a dual-listed, international biotechnology company that creates and develops differentiated antibody therapeutics to fight against cancer and other serious diseases.

Read more

Related contacts

Rama Padmanabhan
Partner, 圣地亚哥
陆培祥
合伙人, 新加坡
Rowook Park
Partner, 圣地亚哥
李若木
合伙人, 上海
Jenny Ge
Associate, 洛杉矶
Ross Eberly
Partner, 洛杉矶
Megan Browdie
Partner, 华盛顿特区
Christopher Kimball
Partner, 华盛顿特区
Jamie Leigh
Partner, 旧金山
Izzy Lubarsky
Partner, 纽约
Barbara Mirza
Partner, 洛杉矶
Sonia Nath
Partner, 华盛顿特区
Jean Park
Partner, 纽约
Lei Shen
Partner, 芝加哥
Stacey A. Bradford
Special Counsel, 华盛顿特区
Jeff Goldman
Special Counsel, 帕罗奥图
Amy Hallman Rice
Special Counsel, 圣地亚哥
Karen Tsai
Special Counsel, 华盛顿特区
王滨
资深顾问, 帕罗奥图
Andrew Bae
Associate, 华盛顿特区
Julia R. Brinton
Special Counsel, 华盛顿特区
Megan Drill
Associate, 圣地亚哥
Mari Dugas
Associate, 华盛顿特区
Allison Kutner
Associate, 纽约
Jiqiang Lin
Associate, 纽约
Tyler Saavedra-Buckley
Associate, 旧金山
汪晨
律师, 上海
徐璨
顾问律师, 上海
Zhijing Yu
Associate, 新加坡
Andy Zachrich
Associate, 圣地亚哥
魏 乐天
法律顾问, 上海

Related Practices & Industries

ProfoundBio Announces $112 Million Oversubscribed Series B

February 14, 2024

Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its $112 million oversubscribed Series B financing.

Read more

Related contacts

陆培祥
合伙人, 新加坡
徐璨
顾问律师, 上海
汪晨
律师, 上海
刘孜翔
律师, 上海
Charlie Kim
Partner, 圣地亚哥
Christopher Kimball
Partner, 华盛顿特区
Natasha Leskovsek
Of Counsel, 华盛顿特区
Sarah Oliai
Associate, 华盛顿特区
魏 乐天
法律顾问, 上海

Related Practices & Industries